Movement Alert｜Spyre Therapeutics Rises 5.02% in Regular Trading, Trading at $93.51

Market Focus07-08

On July 8, Spyre Therapeutics rose 5.02% in regular trading, trading at $93.51 USD/share, with Turnover of $39.24 million.

Within the Biotechnology sector where Spyre Therapeutics belongs, the overall sector performance was mixed. Among individual stocks, Vertex Pharmaceuticals down 1.12%, AbbVie up 0.96%, Gilead Sciences up 3.69%, Moderna down 3.30%, Amgen up 0.43%.

Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease products through best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Its pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181579106?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-08 00:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181579106","market":"us","top_or_hot":-1,"title":"Movement Alert｜Spyre Therapeutics Rises 5.02% in Regular Trading, Trading at $93.51","media":"Market Focus","content":"<p><p>On July 8, Spyre Therapeutics rose 5.02% in regular trading, trading at $93.51 USD/share, with Turnover of $39.24 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, the overall sector performance was mixed. Among individual stocks, Vertex Pharmaceuticals down 1.12%, AbbVie up 0.96%, Gilead Sciences up 3.69%, Moderna down 3.30%, Amgen up 0.43%.</p><p>Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease products through best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Its pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Spyre Therapeutics Rises 5.02% in Regular Trading, Trading at $93.51</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Spyre Therapeutics Rises 5.02% in Regular Trading, Trading at $93.51\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-08 00:16</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 8, Spyre Therapeutics rose 5.02% in regular trading, trading at $93.51 USD/share, with Turnover of $39.24 million.</p><p>Within the Biotechnology sector where Spyre Therapeutics belongs, the overall sector performance was mixed. Among individual stocks, Vertex Pharmaceuticals down 1.12%, AbbVie up 0.96%, Gilead Sciences up 3.69%, Moderna down 3.30%, Amgen up 0.43%.</p><p>Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease products through best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Its pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"","article_id":"1181579106","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181579106","pubTimestamp":1783441018,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 8, Spyre Therapeutics rose 5.02% in regular trading, trading at $93.51 USD/share, with Turnover of $39.24 million.Within the Biotechnology sector where Spyre Therapeutics belongs, the overall...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC"},"translate_title":"走势提示|Spyre Therapeutics常规交易上涨5.02%，报93.51美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":1},"content_text":"On July 8, Spyre Therapeutics rose 5.02% in regular trading, trading at $93.51 USD/share, with Turnover of $39.24 million.Within the Biotechnology sector where Spyre Therapeutics belongs, the overall sector performance was mixed. Among individual stocks, Vertex Pharmaceuticals down 1.12%, AbbVie up 0.96%, Gilead Sciences up 3.69%, Moderna down 3.30%, Amgen up 0.43%.Spyre Therapeutics is a clinical-stage biotechnology company focused on developing next-generation inflammatory bowel disease products through best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches. Its pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181579106","isCrawlerRequest":true}